RNA Aptamer Selection Against SOD1 to Create a Therapeutic for ALS Patients

被引：0
|
作者：
Matthews, Avery [1 ]
机构：
[1] Univ Texas Austin, Austin, TX USA
来源：
JOURNAL OF BIOLOGICAL CHEMISTRY | 2024年 / 300卷 / 03期
关键词：
Aptamer; RNA-based Therapeutics; Amyotrophic Lateral Sclerosis (ALS);
D O I：
10.1016/j.jbc.2024.106031
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
2166
引用
收藏
页码：S148 / S148
页数：1
相关论文
共 50 条
  • [41] Four familial ALS pedigrees discordant for two SOD1 mutations: are all SOD1 mutations pathogenic?
    Felbecker, Ansgar
    Camu, William
    Valdmanis, Paul N.
    Sperfeld, Anne-Dorte
    Waibel, Stefan
    Steinbach, Peter
    Rouleau, Guy A.
    Ludolph, Albert C.
    Andersen, Peter M.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (05): : 572 - 577
  • [42] Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
    Miller, Timothy M.
    Cudkowicz, Merit E.
    Genge, Angela
    Shaw, Pamela J.
    Sobue, Gen
    Bucelli, Robert C.
    Chio, Adriano
    Van Damme, Philip
    Ludolph, Albert C.
    Glass, Jonathan D.
    Andrews, Jinsy A.
    Babu, Suma
    Benatar, Michael
    McDermott, Christopher J.
    Cochrane, Thos
    Chary, Sowmya
    Chew, Sheena
    Zhu, Han
    Wu, Fan
    Nestorov, Ivan
    Graham, Danielle
    Sun, Peng
    McNeill, Manjit
    Fanning, Laura
    Ferguson, Toby A.
    Fradette, Stephanie
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (12): : 1099 - 1110
  • [43] SOD1 aggregates in ALS: Cause, correlate or consequence?
    Brown, RH
    NATURE MEDICINE, 1998, 4 (12) : 1362 - 1364
  • [44] Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS)
    Abati, Elena
    Bresolin, Nereo
    Comi, Giacomo
    Corti, Stefania
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (04) : 295 - 310
  • [45] Destabilization of ALS-variant SOD1 via metal transfer to wild-type SOD1
    Zahler, Collin
    Baumer, Katelyn
    Shaw, Bryan
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [46] ASO Lowering of SOD1 Markedly Extends Survival and Reverses Muscle Denervation in SOD1 ALS Rodent Models
    Miller, Timothy
    McCampbell, Alex
    Cole, Tracy
    Wegener, Amy
    Tomassay, Guilio
    Setnicka, Amy
    Schoch, Kathleen
    Shabsovich, Mark
    Sun, Linhong
    Luo, Yi
    Zhang, Mingdi
    Salzman, David
    Bennett, C. Frank
    Kordasiewicz, Holly
    ANNALS OF NEUROLOGY, 2017, 82 : S103 - S104
  • [47] An examination of wild-type SOD1 in modulating the toxicity and aggregation of ALS-associated mutant SOD1
    Prudencio, Mercedes
    Durazo, Armando
    Whitelegge, Julian P.
    Borchelt, David R.
    HUMAN MOLECULAR GENETICS, 2010, 19 (24) : 4774 - 4789
  • [48] Aberrant DNA and RNA Methylation Occur in Spinal Cord and Skeletal Muscle of Human SOD1 Mouse Models of ALS and in Human ALS: Targeting DNA Methylation Is Therapeutic
    Martin, Lee J.
    Adams, Danya A.
    Niedzwiecki, Mark, V
    Wong, Margaret
    CELLS, 2022, 11 (21)
  • [49] A novel SOD1 gene mutation in a familial ALS patient
    Giannini, F.
    Benigni, M.
    Ricci, C.
    Greco, G.
    Torzini, A.
    Battistini, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 220 - 220
  • [50] SOD1 gene mutations in Italian patients with Sporadic Amyotrophic Lateral Sclerosis (ALS)
    Corrado, L.
    D'Alfonso, S.
    Bergamaschi, L.
    Testa, L.
    Leone, M.
    Nasuelli, N.
    Momigliano-Richiardi, P.
    Mazzini, L.
    NEUROMUSCULAR DISORDERS, 2006, 16 (11) : 800 - 804
12345